Insulin-like growth factor (IGF)-I, IGF-II, IGF-binding protein-2 and pregnancy-associated glycoprotein mRNA in pigs with somatotropin-enhanced fetalgrowth

Citation
Ja. Sterle et al., Insulin-like growth factor (IGF)-I, IGF-II, IGF-binding protein-2 and pregnancy-associated glycoprotein mRNA in pigs with somatotropin-enhanced fetalgrowth, J ENDOCR, 159(3), 1998, pp. 441-450
Citations number
40
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
JOURNAL OF ENDOCRINOLOGY
ISSN journal
00220795 → ACNP
Volume
159
Issue
3
Year of publication
1998
Pages
441 - 450
Database
ISI
SICI code
0022-0795(199812)159:3<441:IGF(II>2.0.ZU;2-Q
Abstract
Fetal growth is increased when pregnant gilts are treated with recombinant porcine somatotropin. The mechanism for increased fetal growth was examined by measuring the expression of IGF-I and -II and IGF-binding protein-2 (IG FBP-2) mRNA in liver and reproductive tissues of somatotropin- and saline-t reated pregnant gilts. Twenty-four pregnant gilts received daily injections of either saline (cont rol; n=12) or 5 mg recombinant porcine somatotropin (n=12) from day 30 to d ay 43 of gestation. Gilts were slaughtered on day 44 of gestation and liver , ovary, placenta, placental uterus (uterus with adjacent placental tissue) and non-placental uterus (region of the necrotic tip) were collected. The mRNAs for somatotropin receptor, IGFs-I and -II, IGFBP-2 and pregnancy-asso ciated glycoprotein (a marker of trophoblast tissue) were analyzed by North ern blotting or ribonuclease protection assay. Gilts treated with somatotropin had heavier fetuses and placentas. The conc entration of mRNA for the components of the IGF system was tissue-dependent . The uterine IGF-I mRNA concentration was greater in non-placental than in placental uterus. The greatest IGF-II mRNA concentration was observed in p lacenta, and adjacent uterine tissue expressed IGFBP-2 mRNA intensely. In n on-placental uterus, IGFBP-2 mRNA was nearly undetectable. Somatotropin-dep endent regulation of IGF-I was only observed in liver, where the greatest s omatotropin receptor mRNA concentration was found. In the pregnant uterus, somatotropin failed to change the concentration of IGF or IGFBP-2 mRNA. Pre gnancy-associated glycoprotein mRNA concentration was decreased by somatotr opin. In summary, increased fetal growth in somatotropin-treated pregnant pigs wa s not associated with changes in IGF or IGFBP-2 mRNA concentration in repro ductive tissues. Other mechanisms, therefore, lead to enhanced fetal growth in somatotropin-treated pregnant pigs.